Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

NCT06643897 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia